CRISPR Leaders Argue Against Total Ban on Human Germline Editing | GenomeWeb

NEW YORK (GenomeWeb) – As scientists from around the world prepare to discuss the implications of genome editing for both science and society, two leaders in the CRISPR/Cas9 field today published essays making the case against a ban on human germline editing.

Jennifer Doudna, of the University of California, Berkeley, and George Church, of the Wyss Institute for Biologically Inspired Engineering and Harvard Medical School, both highlighted the need for regulation, but to different ends. They published their opinions today in Nature.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.